Marco Barbanti
Overview
Explore the profile of Marco Barbanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
388
Citations
5533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa G, Pilgrim T, Saia F, Ribichini F, Gandolfo C, Latib A, et al.
EuroIntervention
. 2025 Mar;
21(5):e282-e284.
PMID: 40028731
No abstract available.
2.
Palmerini T, Saia F, Bruno A, Kim W, Iadanza A, Ghetti G, et al.
J Invasive Cardiol
. 2025 Feb;
PMID: 39993270
Objectives: The authors compared the risk of cerebrovascular events (CVE) with self-expanding vales (SEV) vs balloon-expandable valves (BEV) in patients with or without peripheral artery disease (PAD), stratified by the...
3.
Dipietro E, Costa G, Cali M, Strazzieri O, Motta S, Frittitta V, et al.
Cardiovasc Revasc Med
. 2025 Feb;
PMID: 39986959
Background: Long-term durability and outcomes of transcatheter aortic valve implantation (TAVI) have been reported only with first generation devices. Objectives: To compare clinical efficacy of TAVI with Sapien 3 (Edwards...
4.
Giacobbe F, Morena A, Bruno F, Nebiolo M, De Filippo O, Odeh Y, et al.
Eur Heart J Qual Care Clin Outcomes
. 2025 Feb;
PMID: 39971731
Introduction: The expanding indications for transcatheter aortic valve implatation (TAVI) to younger, lower-risk patients, entails assessing not only the short-term clinical outcomes but also the long-term considerations for future interventions....
5.
Aurigemma C, Trani C, DErrigo P, Barbanti M, Biancari F, Tarantini G, et al.
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860611
Paravalvular leak (PVL) was initially recognized as one of the most common complications after transcatheter aortic valve implantation (TAVI) and has been linked to adverse clinical outcomes, including mortality. This...
6.
Aarts H, van Nieuwkerk A, Hemelrijk K, Salgado Fernandez J, Tchetche D, de Brito Jr F, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(1):89-99.
PMID: 39814498
Background: Transcatheter aortic valve replacement (TAVR) harbors the risk of periprocedural complications that require emergent cardiac surgery, or "surgical bailout." Surgical bailout intends to be lifesaving but is associated with...
7.
Agnello F, Russo C, Laterra G, Ingala S, Saragoni S, Giuffrida M, et al.
Am J Cardiol
. 2024 Dec;
240:71-75.
PMID: 39732311
Atherosclerotic cardiovascular disease is a leading cause of morbidity and mortality globally, significantly influenced by modifiable risk factors, particularly hypercholesterolemia. Despite the availability of effective lipid-reducing drugs, achieving the low-density...
8.
Jia Y, Khokhar A, Pilgrim T, Costa G, Mylotte D, Sammartino S, et al.
JACC Cardiovasc Interv
. 2024 Dec;
18(3):400-402.
PMID: 39641731
No abstract available.
9.
Costa G, Barbanti M, Rosato S, Tarantini G, Tamburino C, Biancari F, et al.
Can J Cardiol
. 2024 Dec;
41(2):264-271.
PMID: 39617051
Background: Head-to-head comparisons of second and third generations of transcatheter heart valves (THVs) are mostly limited to 2-arm studies and to mid-term follow-up. The aim of this study was to...
10.
Guthoff H, Abdel-Wahab M, Kim W, Witberg G, Wienemann H, Thurow M, et al.
JACC Cardiovasc Interv
. 2024 Nov;
17(22):2626-2635.
PMID: 39603776
Background: Prosthesis-patient mismatch after transcatheter aortic valve replacement (TAVR) can be measured echocardiographically (measured prosthesis-patient mismatch [PPMm]) or predicted (predicted prosthesis-patient mismatch [PPMp]) using published effective orifice area (EOA) reference...